Cargando…

Upregulation of DARS2 by HBV promotes hepatocarcinogenesis through the miR-30e-5p/MAPK/NFAT5 pathway

BACKGROUND: Infection with the hepatitis B virus (HBV) is closely associated with the development of hepatocellular carcinoma (HCC). The osmoregulatory transcription factor nuclear factor of activated T-cells 5 (NFAT5) has been shown to play an important role in the development of many types of huma...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Xian, Li, Changsheng, Guo, Tao, Chen, Jing, Wang, Hai-Tao, Wang, Yi-Tao, Xiao, Yu-Sha, Li, Jun, Liu, Pengpeng, Liu, Zhi-Su, Liu, Quan-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649064/
https://www.ncbi.nlm.nih.gov/pubmed/29052520
http://dx.doi.org/10.1186/s13046-017-0618-x
_version_ 1783272493309493248
author Qin, Xian
Li, Changsheng
Guo, Tao
Chen, Jing
Wang, Hai-Tao
Wang, Yi-Tao
Xiao, Yu-Sha
Li, Jun
Liu, Pengpeng
Liu, Zhi-Su
Liu, Quan-Yan
author_facet Qin, Xian
Li, Changsheng
Guo, Tao
Chen, Jing
Wang, Hai-Tao
Wang, Yi-Tao
Xiao, Yu-Sha
Li, Jun
Liu, Pengpeng
Liu, Zhi-Su
Liu, Quan-Yan
author_sort Qin, Xian
collection PubMed
description BACKGROUND: Infection with the hepatitis B virus (HBV) is closely associated with the development of hepatocellular carcinoma (HCC). The osmoregulatory transcription factor nuclear factor of activated T-cells 5 (NFAT5) has been shown to play an important role in the development of many types of human cancers. The role of NFAT5 in HBV-associated HCC has never previously been investigated. METHODS: We compared expression profiles of NFAT5, DARS2 and miR-30e-5p in HCC samples, adjacent nontumor tissues and different hepatoma cell lines by quantitative real-time polymerase chain reaction and /or Western blot. Clinical data of HCC patients for up to 80 months were analyzed. The regulatory mechanisms upstream and convergent downstream pathways of NFAT5 in HBV-associated HCC were investigated by ChIP-seq, MSP, luciferase report assay and bioinformation anaylsis. RESULTS: We first found that higher levels of NFAT5 expression predict a good prognosis, suggesting that NFAT5 is a potential tumor-suppressing gene, and verified that NFAT5 promotes hepatoma cell apoptosis and inhibits cell growth in vitro. Second, our results showed that HBV could suppress NFAT5 expression by inducing hypermethylation of the AP1-binding site in the NFAT5 promoter in hepatoma cells. In addition, HBV also inhibited NFAT5 through miR-30e-5p targeted MAP4K4, and miR-30e-5p in turn inhibited HBV replication. Finally, we demonstrated that NFAT5 suppressed DARS2 by directly binding to its promoter. DARS2 was identified as an HCC oncogene that promotes HCC cell cycle progression and inhibits HCC cell apoptosis. CONCLUSION: HBV suppresses NFAT5 through the miR-30e-5p/mitogen-activated protein kinase (MAPK) signaling pathway upstream of NFAT5 and inhibits the NFAT5 to enhance HCC tumorigenesis via the downstream target genes of DARS2. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13046-017-0618-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5649064
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-56490642017-10-26 Upregulation of DARS2 by HBV promotes hepatocarcinogenesis through the miR-30e-5p/MAPK/NFAT5 pathway Qin, Xian Li, Changsheng Guo, Tao Chen, Jing Wang, Hai-Tao Wang, Yi-Tao Xiao, Yu-Sha Li, Jun Liu, Pengpeng Liu, Zhi-Su Liu, Quan-Yan J Exp Clin Cancer Res Research BACKGROUND: Infection with the hepatitis B virus (HBV) is closely associated with the development of hepatocellular carcinoma (HCC). The osmoregulatory transcription factor nuclear factor of activated T-cells 5 (NFAT5) has been shown to play an important role in the development of many types of human cancers. The role of NFAT5 in HBV-associated HCC has never previously been investigated. METHODS: We compared expression profiles of NFAT5, DARS2 and miR-30e-5p in HCC samples, adjacent nontumor tissues and different hepatoma cell lines by quantitative real-time polymerase chain reaction and /or Western blot. Clinical data of HCC patients for up to 80 months were analyzed. The regulatory mechanisms upstream and convergent downstream pathways of NFAT5 in HBV-associated HCC were investigated by ChIP-seq, MSP, luciferase report assay and bioinformation anaylsis. RESULTS: We first found that higher levels of NFAT5 expression predict a good prognosis, suggesting that NFAT5 is a potential tumor-suppressing gene, and verified that NFAT5 promotes hepatoma cell apoptosis and inhibits cell growth in vitro. Second, our results showed that HBV could suppress NFAT5 expression by inducing hypermethylation of the AP1-binding site in the NFAT5 promoter in hepatoma cells. In addition, HBV also inhibited NFAT5 through miR-30e-5p targeted MAP4K4, and miR-30e-5p in turn inhibited HBV replication. Finally, we demonstrated that NFAT5 suppressed DARS2 by directly binding to its promoter. DARS2 was identified as an HCC oncogene that promotes HCC cell cycle progression and inhibits HCC cell apoptosis. CONCLUSION: HBV suppresses NFAT5 through the miR-30e-5p/mitogen-activated protein kinase (MAPK) signaling pathway upstream of NFAT5 and inhibits the NFAT5 to enhance HCC tumorigenesis via the downstream target genes of DARS2. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13046-017-0618-x) contains supplementary material, which is available to authorized users. BioMed Central 2017-10-19 /pmc/articles/PMC5649064/ /pubmed/29052520 http://dx.doi.org/10.1186/s13046-017-0618-x Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Qin, Xian
Li, Changsheng
Guo, Tao
Chen, Jing
Wang, Hai-Tao
Wang, Yi-Tao
Xiao, Yu-Sha
Li, Jun
Liu, Pengpeng
Liu, Zhi-Su
Liu, Quan-Yan
Upregulation of DARS2 by HBV promotes hepatocarcinogenesis through the miR-30e-5p/MAPK/NFAT5 pathway
title Upregulation of DARS2 by HBV promotes hepatocarcinogenesis through the miR-30e-5p/MAPK/NFAT5 pathway
title_full Upregulation of DARS2 by HBV promotes hepatocarcinogenesis through the miR-30e-5p/MAPK/NFAT5 pathway
title_fullStr Upregulation of DARS2 by HBV promotes hepatocarcinogenesis through the miR-30e-5p/MAPK/NFAT5 pathway
title_full_unstemmed Upregulation of DARS2 by HBV promotes hepatocarcinogenesis through the miR-30e-5p/MAPK/NFAT5 pathway
title_short Upregulation of DARS2 by HBV promotes hepatocarcinogenesis through the miR-30e-5p/MAPK/NFAT5 pathway
title_sort upregulation of dars2 by hbv promotes hepatocarcinogenesis through the mir-30e-5p/mapk/nfat5 pathway
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649064/
https://www.ncbi.nlm.nih.gov/pubmed/29052520
http://dx.doi.org/10.1186/s13046-017-0618-x
work_keys_str_mv AT qinxian upregulationofdars2byhbvpromoteshepatocarcinogenesisthroughthemir30e5pmapknfat5pathway
AT lichangsheng upregulationofdars2byhbvpromoteshepatocarcinogenesisthroughthemir30e5pmapknfat5pathway
AT guotao upregulationofdars2byhbvpromoteshepatocarcinogenesisthroughthemir30e5pmapknfat5pathway
AT chenjing upregulationofdars2byhbvpromoteshepatocarcinogenesisthroughthemir30e5pmapknfat5pathway
AT wanghaitao upregulationofdars2byhbvpromoteshepatocarcinogenesisthroughthemir30e5pmapknfat5pathway
AT wangyitao upregulationofdars2byhbvpromoteshepatocarcinogenesisthroughthemir30e5pmapknfat5pathway
AT xiaoyusha upregulationofdars2byhbvpromoteshepatocarcinogenesisthroughthemir30e5pmapknfat5pathway
AT lijun upregulationofdars2byhbvpromoteshepatocarcinogenesisthroughthemir30e5pmapknfat5pathway
AT liupengpeng upregulationofdars2byhbvpromoteshepatocarcinogenesisthroughthemir30e5pmapknfat5pathway
AT liuzhisu upregulationofdars2byhbvpromoteshepatocarcinogenesisthroughthemir30e5pmapknfat5pathway
AT liuquanyan upregulationofdars2byhbvpromoteshepatocarcinogenesisthroughthemir30e5pmapknfat5pathway